|
BOD1L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.157000E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.219000E-04 |
| Normal-vs-Stage2 |
4.792400E-02 |
| Normal-vs-Stage3 |
1.051830E-02 |
| Normal-vs-Stage4 |
1.928640E-01 |
| Stage1-vs-Stage2 |
9.674200E-01 |
| Stage1-vs-Stage3 |
9.764800E-01 |
| Stage1-vs-Stage4 |
9.247200E-01 |
| Stage2-vs-Stage3 |
9.478800E-01 |
| Stage2-vs-Stage4 |
9.523400E-01 |
| Stage3-vs-Stage4 |
9.033800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.804500E-04 |
| Normal-vs-AfricanAmerican |
1.099910E-02 |
| Normal-vs-Asian |
1.502190E-03 |
| Caucasian-vs-AfricanAmerican |
9.110200E-01 |
| Caucasian-vs-Asian |
3.478600E-01 |
| AfricanAmerican-vs-Asian |
3.180800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.32900000000091E-05 |
| Normal-vs-Female |
5.948400E-01 |
| Male-vs-Female |
7.759300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.605800E-02 |
| Normal-vs-Extreme_Weight |
1.82378999999955E-05 |
| Normal-vs-Obese |
1.156010E-01 |
| Normal-vs-Extreme_Obese |
9.043400E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.367200E-01 |
| Normal_Weight-vs-Obese |
3.793000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.654000E-01 |
| Extreme_Weight-vs-Obese |
1.483620E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.642800E-01 |
| Obese-vs-Extreme_Obese |
1.575830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.028400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.024100E-02 |
| Normal-vs-Age(61-80Yrs) |
3.63010000000719E-05 |
| Normal-vs-Age(81-100Yrs) |
5.096600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.393200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.466040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.416230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.252300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.378400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.420400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.212600E-04 |
| Normal-VS-Type2 PRCC |
2.463300E-03 |
| Normal-VS-KIRP CIMP |
7.217200E-01 |
| Normal-VS-Unclassified PRCC |
1.924030E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.768000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.063800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.479800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.751800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.728800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.282600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.52320999999844E-05 |
| Normal-vs-N1 |
5.127800E-01 |
| Normal-vs-N2 |
3.542200E-01 |
| N0-vs-N1 |
3.289700E-02 |
| N0-vs-N2 |
2.995400E-01 |
| N1-vs-N2 |
8.092400E-01 |
|
|
